Ariel Gonzalez, Jennifer Bell recognized by The Hill as Top Lobbyists for 2021.
Jennifer Bell, founding partner, provided political context for and strategic insights into “The Biden Administration, the 117 Congress, and What We Might See in Healthcare” at the Society of Hospital Medicine Annual Meeting.
Check out the latest video interview from the National Association of Elder Law Attorneys’ Federal Advocacy Committee co-chairs with Jennifer Bell of Chamber Hill Strategies and NAELA’s Director of Advocacy, David M. Goldfarb, on what members can expect inside the beltway in 2021; how NAELA navigated advocacy during the COVID-19 crisis; and more!
In part two of A&M Healthcare Industry Group’s podcast series, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, continued their discussion with Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, on the Biden Administration’s impact on healthcare policy by focusing on President Biden’s campaign promises for healthcare and how and when they may come to fruition. They also discussed the important issue of prescription drug pricing reform and how we can anticipate the Biden Administration and Congress may deal with the issue.
A&M’s Healthcare Industry Group Co-Head, Peter Urbanowicz, is joined by Dr. David Shulkin, Ninth Secretary of the U.S. Department of Veterans Affairs and Jennifer Bell, Founding Partner of Chamber Hill Strategies, as they discussed and share perspectives on what the Healthcare landscape and future look like under the Biden Administration.
In part one, Dr. Shulkin and Ms. Bell discussed the role of the cabinet secretary and how the White House and cabinet agencies shape healthcare policy. They also discussed the latest $1.9 trillion COVID-19 stimulus bill and how the bill will affect the ACA Exchanges and Medicaid. And, with Democrats holding the Presidency and both Houses of Congress right now, our experts also weigh in on what the future of federal healthcare policy looks like over the next four years.
Jennifer Bell, founding partner, previewed what 2021 looks like for drug pricing, 340B, and oncology care at the annual meeting of the Association of Cancer Executives.
Jennifer Bell, Chamber Hill Strategies, was named Top Lobbyist in the Hired Gun category.
Jennifer Bell, Chamber Hill Strategies, was named Top Lobbyist by The Hill.
Jennifer Bell, founding partner, presented during “Women at the Helm,” a featured discussion about women going out on their own to open policy shops. The organization 131 & Counting brings together women congressional staff and women policy professionals to discuss insights into organizational diversity both on and off the Hill; the proliferation of women-owned firms and contractors; and navigate how gender matters in policy areas once mostly exclusive to men.
Jennifer Bell, founding partner, along with the oncology strategic planning team at ECG Management Consultants, discussed the evolving reimbursement environment for oncology practices and presented practical solutions in this hour-long webinar.
Jennifer Bell, founding partner, presented the outlook for legislation and regulation on prescription drug prices, health care costs, and provider payments at the esteemed annual Princeton Conference, hosted by the Heller School for Social Policy and Management at Brandeis University.